Ervaccine Technologies – Trademark Portfolio
Entity Type: 99
Ervaccine Technologies holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include ERVACCINE and ERVIMMUNE. The owner is based in Lyon Cedex 08.
Centre Léon Bérard 28 Rue Laennec
Lyon Cedex 08 69373 , FR
Showing of trademarks Trademarks
Trademark Classifications
Ervaccine Technologies's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Ervaccine Technologies have?
Ervaccine Technologies has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending.
What trademark classes does Ervaccine Technologies file in?
Ervaccine Technologies files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Ervaccine Technologies's most well-known trademarks?
Ervaccine Technologies's registered trademark portfolio includes well-known marks such as ERVACCINE and ERVIMMUNE. These are among 2 currently registered trademarks in the portfolio.
What is Ervaccine Technologies's trademark registration success rate?
Ervaccine Technologies has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.